CommercialCoverageMedium impact
Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
Blue Cross & Blue Shield of Mississippi·MS · Orthopedics, Sports Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi has updated their policy for autologous chondrocyte implantation (ACI) for knee cartilage defects, establishing specific medical necessity criteria including patient age limits, lesion size requirements, and joint stability requirements. The policy covers MACI procedures for full-thickness cartilage defects meeting strict criteria but considers ACI for other joints investigational.
Action Required
Immediately: Billing team must review all pending and future autologous chondrocyte implantation claims to ensure they meet BCBS Mississippi's specific criteria: patient must be skeletally mature but under 55 years old, lesions must be at least 1.5cm² on weight-bearing surfaces of femoral condyles/trochlea/patella, minimal surrounding cartilage damage, and normal knee alignment. Update prior authorization requests to include documentation of these criteria. Claims for ACI on joints other than the knee will be denied as investigational.